UBS AM’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $62.5M | Sell |
|
|||||
|
2024
Q3 | $52.4M | Sell |
|
|||||
|
2024
Q2 | $63.5M | Buy |
|
|||||
|
2024
Q1 | $3.44M | Buy |
|
|||||
|
2023
Q4 | $4.13M | Buy |
|
|||||
|
2023
Q3 | $4.01M | Buy |
|
|||||
|
2023
Q2 | $3.25M | Hold |
|
|||||
|
2023
Q1 | $3.25M | Buy |
|
|||||
|
2022
Q4 | $3.08M | Buy |
|
|||||
|
2022
Q3 | $3.28M | Sell |
|
|||||
|
2022
Q2 | $3.56M | Buy |
|
|||||
|
2022
Q1 | $2.71M | Buy |
|
|||||
|
2021
Q4 | $2.35M | Buy |
|
|||||
|
2021
Q3 | $1.98M | Buy |
|
|||||
|
2021
Q2 | $1.79M | Buy |
|
|||||
|
2021
Q1 | $1.58M | Buy |
|
|||||
|
2020
Q4 | $332K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $727K | Buy |
|